Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis

被引:254
|
作者
Hansen, T [1 ]
Kunkel, M
Weber, A
Kirkpatrick, CJ
机构
[1] Johannes Gutenberg Univ Mainz, Inst Pathol, Langenbeckstr 1, D-55101 Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Clin Maxillofacial Surg, D-55101 Mainz, Germany
关键词
Actinomyces; bisphosphonate; infected osteoradionecrosis; osteoclast; osteonecrosis; pseudoepitheliomatous hyperplasia;
D O I
10.1111/j.1600-0714.2006.00391.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Patients treated with bisphosphonates because of bone metastases have been shown to develop osteonecrosis of the jaws. In the present study, we examined the histologic findings of these cases. As similarities between this disorder and infected osteoradionecrosis (IORN) are described, both lesions were compared. Methods: We investigated eight patients with bisphosphonate treatment and osteonecrosis (four female, four male; median age: 65.6 years; cancer: multiple myeloma in five patients, breast cancer in three patients; mandibular involvement in five patients, maxillar involvement in three cases), and 10 patients suffering from IORN (all male; median age: 61.3 years; cancer: squamous cell carcinoma in nine patients, adenoid cystic carcinoma in one patient; mandibular involvement in all cases). Multicentric and bilateral involvement was common in the bisphosphonate group. Histologically, the bone revealed diffuse and patchy areas of necrosis in the bisphosphonate group, while in IORN osteonecrosis was larger and not diffusely distributed. Results: In all cases, we found Actinomyces attached to the necrotic bone tissue. In five of eight bisphosphonates cases, and in six of 10 IORN cases, numerous osteoclasts could be detected close to vital bone exhibiting signs of bone resorption. Pseudoepitheliomatous hyperplasia (PH) was revealed in five of eight bisphosphonate patients, and in seven of 10 IORN patients. Conclusion: We conclude that Actinomyces is involved in the chronic, non-healing inflammatory processes as a characteristic feature of both diseases. Together with the associated presence of increased osteoclast numbers, we suggest that both factors may be involved in osteolytic mechanisms.
引用
收藏
页码:155 / 160
页数:6
相关论文
共 49 条
  • [21] Renal toxicity and osteonecrosis of the jaw in cancer patients treated with bisphosphonates: a long-term retrospective analysis
    Bonomi, M.
    Nortilli, R.
    Molino, A.
    Sava, T.
    Santo, A.
    Caldara, A.
    Cetto, G. L.
    MEDICAL ONCOLOGY, 2010, 27 (02) : 224 - 229
  • [22] Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates
    Bagan, Jose V.
    Jimenez, Yolanda
    Gomez, Dolores
    Sirera, Rafael
    Poveda, Rafael
    Scully, Crispian
    ORAL ONCOLOGY, 2008, 44 (11) : 1088 - 1089
  • [23] The Importance of Alliance between Hematologists and Dentists: A Retrospective Study on the Development of Bisphosphonates Osteonecrosis of the Jaws (Bronj) in Multiple Myeloma Patients
    Bacci, Christian
    Cerrato, Alessia
    Dotto, Virginia
    Zambello, Renato
    Barila, Gregorio
    Lico, Albana
    Semenzato, Gianpietro
    Stellini, Edoardo
    Zanette, Gastone
    DENTISTRY JOURNAL, 2021, 9 (02)
  • [24] Bisphosphonates Induce Apoptosis of Circulating Endothelial Cells in Multiple Myeloma Patients and in Subjects with Bisphosphonate-Induced Osteonecrosis of the Jaws
    Allegra, Alessandro
    Alonci, Andrea
    Penna, Giuseppa
    Granata, Angela
    Siniscalchi, Enrico Nastro
    Oteri, Giacomo
    Loddo, Saverio
    Teti, Diana
    Ciccu, Domenico
    De Ponte, Francesco Saverio
    Musolino, Caterina
    ACTA HAEMATOLOGICA, 2010, 124 (02) : 79 - 85
  • [25] Incidence of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in patients taking bisphosphonates for osteoporosis treatment—a grossly underestimated risk?
    Peter Johannes Hansen
    Michael Knitschke
    Florian Guy Draenert
    Sebastian Irle
    Andreas Neff
    Clinical Oral Investigations, 2013, 17 : 1829 - 1837
  • [26] Risk of osteonecrosis in patients taking bisphosphonates for prevention of osteoporosis: a systematic review and meta-analysis
    S.-H. Lee
    S.-S. Chang
    M. Lee
    R.-C. Chan
    C.-C. Lee
    Osteoporosis International, 2014, 25 : 1131 - 1139
  • [27] Risk of osteonecrosis in patients taking bisphosphonates for prevention of osteoporosis: a systematic review and meta-analysis
    Lee, S-H
    Chang, S-S
    Lee, M.
    Chan, R-C
    Lee, C-C
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 (03) : 1131 - 1139
  • [28] Extraction socket healing in rats treated with bisphosphonate: Animal model for bisphosphonate related osteonecrosis of jaws in multiple myeloma patients
    Ali-Erdem, Mehmet
    Burak-Cankaya, Abdulkadir
    Cemil-Isler, Sabri
    Demircan, Sabit
    Soluk, Merva
    Kasapoglu, Cetin
    Korhan-Oral, Cuneyt
    MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2011, 16 (07): : C879 - C883
  • [29] Incidence of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in patients taking bisphosphonates for osteoporosis treatment-a grossly underestimated risk?
    Hansen, Peter Johannes
    Knitschke, Michael
    Draenert, Florian Guy
    Irle, Sebastian
    Neff, Andreas
    CLINICAL ORAL INVESTIGATIONS, 2013, 17 (08) : 1829 - 1837
  • [30] Osteonecrosis of the Jaw after Implant Surgery in Patients Treated with Bisphosphonates - A Presentation of Six Consecutive Cases
    Tam, Yvonne
    Kar, Kian
    Nowzari, Hessam
    Cha, Hyun-Suk
    Ahn, Kang-Min
    CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, 2014, 16 (05) : 751 - 761